Sector ratings Legend Biotech Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 15/04/2026 BST			5-day change	1st Jan Change
20.52 ^USD	+9.79%		+12.13%	-5.61%

04-14	Genscript Biotech Associate Logs $597 Million in Q1 Sales of Carvykti	MT
03-11	Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LEGEND BIOTECH CORPORATION	3.46B		BB
ARGENX SE	51.73B		A
WUXI APPTEC CO., LTD.	47.14B		AAA
INSMED INCORPORATED	33.11B	-	A	-		-
BIONTECH SE	24.89B	-	-	-		-
WUXI BIOLOGICS (CAYMAN) INC.	19.66B		AAA
GENMAB A/S	17.86B		A
AKESO, INC.	16.22B		B			-
SUMMIT THERAPEUTICS INC.	16.17B	-	-	-		-
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	14.44B	-	AA	-		-
MADRIGAL PHARMACEUTICALS, INC.	12.04B	-	B	-		-
EXELIXIS, INC.	11.91B		BB
REMEGEN CO., LTD.	10.23B		-
ARROWHEAD PHARMACEUTICALS, INC.	9.34B	-	BB	-		-
SAMSUNG EPIS HOLDINGS CO., LTD.	9.14B		-				-
VAXCYTE, INC.	9.03B	-	BBB	-		-
NUVALENT, INC.	8.26B	-	CCC	-		-
CEREVEL THERAPEUTICS HOLDINGS, INC.	8.19B	-	-	-	-	-	-	-
CYTOKINETICS, INCORPORATED	8.17B	-	AA	-		-
IMMUNITYBIO, INC.	7.85B	-	CCC	-		-
Average	16.94B		A
Weighted average by Cap.			A